Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label study of deferiprone in Friedreich's ataxia
2009-010865-22Phase 2Active
- Sponsor
- ApoPharma Inc.
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of deferiprone in Friedreich ataxia (FA), sponsored by ApoPharma Inc. Primary endpoint: Long-term safety and tolerability of deferiprone. Started Mar 2009; status: active.
02
Drugs
deferiprone
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2009-010865-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010865-22.